DDAVP—The Multipotent Drug in Patients With Coagulopathies
- 30 April 1991
- journal article
- review article
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 5 (2), 132-144
- https://doi.org/10.1016/s0887-7963(91)70200-9
Abstract
No abstract availableThis publication has 57 references indexed in Scilit:
- Consistency of responses to repeated DDAVP infusions in patients with von Willebrand's disease and hemophilia ABlood, 1989
- Hemodynamic and Coagulation Responses to 1-Desamino[8-D-Arginine] Vasopressin in Patients with Congenital Nephrogenic Diabetes InsipidusNew England Journal of Medicine, 1988
- Effects of a specific antidiuretic agonist on cardiac output and its distribution in intact and anephric dogsClinical Science, 1988
- Characterization of Acute Hemodynamic Effects of Antidiuretic Agonists in Conscious DogsJournal of Cardiovascular Pharmacology, 1988
- Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding timeBlood, 1986
- Response of Patients with Mild and Moderate Hemophilia A and von Willebrand's Disease to Treatment with DesmopressinAnnals of Internal Medicine, 1985
- Mechanism of Plasminogen Activator and Factor VIII Increase after Vasoactive DrugsBritish Journal of Haematology, 1975
- A NEW VASOPRESSIN ANALOGUE AND FIBRINOLYSISThe Lancet, 1973
- Amino acids and peptides. LXXI. Synthesis of 1-deamino-8-D-γ-aminobutyrine-vasopressin, 1-deamino-8-D-lysine-vasopressin, and 1-deamino-8-D-arginine-vasopressinCollection of Czechoslovak Chemical Communications, 1967
- Increase in antihaemophilic globulin activity following infusion of adrenalineThe Journal of Physiology, 1961